[b]Wednesday, December 02 2009 1:30 AM, EST New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology[/b] PR Newswire "US Press Releases " SEATTLE , Dec. 2 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA:
CTIC) announced today that Ruth Pettengell , M.D. of St. George's Hospital , University of London , the lead ...